Nexia announces results of Pharmathene Merger

24-Aug-2007

Nexia Biotechnologies Ltd. announced that PharmAthene Inc. has announced that the stockholders of Healthcare Acquisition Corp. have approved the proposed merger of HAQ and PharmAthene. PharmAthene has further announced that a certificate of merger has been filed, that the name of the merged company is PharmAthene Inc. and that the common shares of PharmAthene are presently trading on the American Stock Exchange under the symbol "PIP". Nexia has been advised that it will hold approximately 1,715,975 shares representing approximately 7.2% of the merged entity.

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance